121 related articles for article (PubMed ID: 1306105)
21. Activity of ornithine decarboxylase (ODC) and polyamine levels as biochemical markers of malignancy in human brain tumors.
Ernestus RI; Röhn G; Schröder R; Klug N; Hossmann KA; Paschen W
Acta Histochem Suppl; 1992; 42():159-64. PubMed ID: 1584960
[TBL] [Abstract][Full Text] [Related]
22. L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma.
Ma Q; Wang Y; Gao X; Ma Z; Song Z
Clin Cancer Res; 2007 Dec; 13(24):7407-12. PubMed ID: 18094424
[TBL] [Abstract][Full Text] [Related]
23. Expansion of the epithelial cell proliferative compartment and frequency of adenomatous polyps in the colon correlate with the strength of family history of colorectal cancer.
Gerdes H; Gillin JS; Zimbalist E; Urmacher C; Lipkin M; Winawer SJ
Cancer Res; 1993 Jan; 53(2):279-82. PubMed ID: 8417821
[TBL] [Abstract][Full Text] [Related]
24. Incidence and recurrence rates of colorectal adenomas in first-degree asymptomatic relatives of patients with colon cancer.
Fossi S; Bazzoli F; Ricciardiello L; Nicolini G; Zagari RM; Pozzato P; Palli D; Roda E
Am J Gastroenterol; 2001 May; 96(5):1601-4. PubMed ID: 11374706
[TBL] [Abstract][Full Text] [Related]
25. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
26. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
27. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
[TBL] [Abstract][Full Text] [Related]
28. Rectal mucosal ornithine decarboxylase activity is not a useful marker of risk for colorectal neoplasia.
Sandler RS; Ulshen MH; Lyles CM; McAuliffe CA; Fuller CR
Dig Dis Sci; 1992 Nov; 37(11):1718-24. PubMed ID: 1425072
[TBL] [Abstract][Full Text] [Related]
29. Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk.
Roncucci L; Mora E; Mariani F; Bursi S; Pezzi A; Rossi G; Pedroni M; Luppi D; Santoro L; Monni S; Manenti A; Bertani A; Merighi A; Benatti P; Di Gregorio C; de Leon PM
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2291-7. PubMed ID: 18768495
[TBL] [Abstract][Full Text] [Related]
30. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years.
Strul H; Kariv R; Leshno M; Halak A; Jakubowicz M; Santo M; Umansky M; Shirin H; Degani Y; Revivo M; Halpern Z; Arber N
Am J Gastroenterol; 2006 Feb; 101(2):255-62. PubMed ID: 16454827
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
[TBL] [Abstract][Full Text] [Related]
32. [Colorectal cancer: study on 365 cases].
Celestino A; Castillo T; Frisancho O; Contardo C; Espejo H; Tomioka C; Navarrete J
Rev Gastroenterol Peru; 1996; 16(3):187-96. PubMed ID: 12165782
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for colorectal adenomas among immediate family members of patients with colorectal cancer in Taiwan: a case-control study.
Tung SY; Wu CS
Am J Gastroenterol; 2000 Dec; 95(12):3624-8. PubMed ID: 11151903
[TBL] [Abstract][Full Text] [Related]
34. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer.
Akedo I; Ishikawa H; Ioka T; Kaji I; Narahara H; Ishiguro S; Suzuki T; Otani T
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):925-30. PubMed ID: 11535542
[TBL] [Abstract][Full Text] [Related]
36. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.
Sidelnikov E; Bostick RM; Flanders WD; Long Q; Seabrook ME
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2965-73. PubMed ID: 19861524
[TBL] [Abstract][Full Text] [Related]
37. The role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening: a prospective "back-to-back" endoscopic study.
Hurlstone DP; Karajeh M; Cross SS; McAlindon ME; Brown S; Hunter MD; Sanders DS
Am J Gastroenterol; 2005 Oct; 100(10):2167-73. PubMed ID: 16181364
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for advanced colorectal adenomas: a pooled analysis.
Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
[TBL] [Abstract][Full Text] [Related]
39. Relationship of ornithine decarboxylase activity and human colon tumorigenesis.
Takami H; Koudaira H; Kodaira S
Jpn J Clin Oncol; 1994 Jun; 24(3):141-3. PubMed ID: 8007423
[TBL] [Abstract][Full Text] [Related]
40. Surveillance in Lynch syndrome: how aggressive?
Lanspa SJ; Jenkins JX; Cavalieri RJ; Smyrk TC; Watson P; Lynch J; Lynch HT
Am J Gastroenterol; 1994 Nov; 89(11):1978-80. PubMed ID: 7942721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
